Sun Nuclear presenta la cartera de gestión de calidad en evolución y expansión en la reunión ESTRO 2023

Oferta integral de productos en radioterapia y control de calidad de imágenes de diagnóstico MELBOURNE, Fla., 12 de mayo de 2023 /PRNewswire/ — Sun Nuclear, una empresa de Mirion Medical (Mirion, NYSE: MIR), destacará las últimas innovaciones para la gestión de la calidad en la reunión anual de ESTRO que comenzará el viernes 12 de mayo … Read more

Sun Nuclear Showcases Evolving and Expanding Quality Management Portfolio at ESTRO 2023 Meeting

Comprehensive Product Offering across Radiation Therapy & Diagnostic Imaging QA MELBOURNE, Fla., May 12, 2023 /PRNewswire/ — Sun Nuclear, a Mirion Medical company (Mirion, NYSE: MIR), will highlight the latest innovations for Quality Management at the ESTRO Annual Meeting beginning Friday, May 12, in Vienna, Austria. Industry gold standard and novel Radiation Therapy and Diagnostic Imaging … Read more

Science for America Reports Two Promising Approaches To Fusion Power

Building on recent scientific advances, methods may speed progress, decrease cost, and simplify engineering  CAMBRIDGE, Mass., May 12, 2023 /PRNewswire/ — Science for America (SfA), a non-profit “solutions incubator,” announced today the release of a white paper: “New Opportunities for Fusion Power.” Building on recent scientific advances, the SfA white paper describes two different promising approaches … Read more

Nemours Children’s CEO Releases New eBook on Essentials of Health Beyond the Doctor’s Office

Book offers engaging insights on raising healthier kids and becoming a healthier nation JACKSONVILLE, Fla., May 12, 2023 /PRNewswire/ — R. Lawrence Moss, MD, president and CEO of Nemours Children’s Health, today released a new eBook, Finding Health by Looking in the Right Place: How Understanding What Actually Creates Health Can Fix U.S. Healthcare. The … Read more

Resultados del estudio clínico de fase I del anticuerpo bifuncional PD-1/CTLA-4 de Qilu Pharma

-Resultados del estudio clínico de fase I del anticuerpo bifuncional PD-1/CTLA-4 Iparomlimab/Tuvonralimab de Qilu Pharma publicado en línea en Journal of Hematology & Oncology JINAN, China, 12 de mayo de 2023 /PRNewswire/ — El 8 de mayo de 2023, Journal of Hematology & Oncology (JHO, 2022 factor de impacto de 23.168) publicó los resultados del … Read more

Bringing Together Thought Leaders And Innovators

CHICAGO , May 12, 2023 /PRNewswire/ — MarketsandMarkets Conferences is a leading organizer of global conferences and events in the fields of Pharma, Healthcare, and Life Sciences. We are delighted to announce our forthcoming Infectious Disease and Molecular Diagnostics Conference, which is scheduled to take place in Boston, USA, on 19th-20th October 2023. The event will … Read more

Elevating Women’s Wellness with InMode Aesthetics

David A. Marcantel, MD, FACOG, Medical Director All procedures are carried out using the Empower RF or Optimas system, machines encompassing a suite of technologies all in one place. In most cases, non-invasive and minimally invasive treatments for tightening or rejuvenation are pain-free, resulting in an enhanced patient experience through better overall results from a single treatment session. For additional information on InMode aesthetics … Read more

NIH STUDY FINDS ASSOCIATION BETWEEN GESTATIONAL DIABETES, MATERNAL DEPRESSION, AND EARLY CHILDHOOD BEHAVIOR PROBLEMS

DURHAM, N.C., May 12, 2023 /PRNewswire/ — Gestational diabetes, prenatal depression, and postpartum depression were each individually associated with higher levels of early childhood behavior problems such as attentional problems, anxiety, and depression in new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health. Previous research has … Read more

Sector to Reach $21.7 Billion by 2031 at a 9.6% CAGR

DUBLIN, May 12, 2023 /PRNewswire/ — The “Global Acute Bacterial Skin and Skin Structure Infections Treatment Market Report and Forecast 2023-2031” report has been added to  ResearchAndMarkets.com’s offering. The global acute bacterial skin and skin structure infections (ABSSSI) treatment market size was valued at USD 9.5 billion in 2022 and is projected to grow at a … Read more